Goodbye Lymphomatoid Granulomatosis | Center for Cancer Research
A clinical trial that has been running for 30 years leads to a highly effective treatment for the rare precancerous condition lymphomatoid granulomatosis.
A clinical trial that has been running for 30 years leads to a highly effective treatment for the rare precancerous condition lymphomatoid granulomatosis.
Data from the phase 3 CRC-PREVENT trial support the sensitivity of ColoSense in the detection of colorectal cancer.
One of the first HPV self-collection solutions has been approved by the FDA, which can identify women at risk of developing cervical cancer.
Precursor conditions are early phases of diseases that may develop into cancers such as lymphoma, leukemia, and multiple myeloma.
NOTCH3 signaling activates tumor-associated mesenchymal cells, increases collagen production, and augments cell invasion in lung adenocarcinoma, suggesting its critical role in remodeling tumor stroma.
Abstract. Advances in cancer prevention, early detection and treatments have led to unprecedented progress against cancer. However, these advances have not benefited everyone equally. Because…
Through clinical research led by our Katy Rezvani, M.D., Ph.D., CAR NK cell therapy has now become an experimental treatment option for multiple cancers . Learn…
The FDA has approved one of the first human papillomavirus self-collection solutions for use in the US.
Roche announced the FDA approval of its human papillomavirus (HPV) self-collection solution—one of the first of such tests available in the United States.
Samilia Obeng-Gyasi, MD, MPH, highlights a study on the association between neighborhood opportunity with all-cause mortality in patients with breast cancer.
AbstractBackground:. Distinguishing ovarian cancer from other gynecological malignancies is crucial for patient survival yet hindered by non-specific symptoms and limited understanding of ovarian cancer pathogenesis.…